Proteinuria Progression in Type 2 Diabetes Patients Post-COVID-19, 688 Cases

688 patients with type 2 diabetes mellitus confirmed to have COVID-19 infection were compared to 502 pre-pandemic uninfected patients in this retrospective study. The data, published by Jiajun Wu on figshare in April 2026, shows that 8.5% of infected participants experienced proteinuria progression, with overweight/obese status associated with a 2.682-fold higher risk.

Use Cases

• Assessing the association between BMI and proteinuria progression based on body mass index categorization.
• Comparing renal complication risks between post-COVID-19 and pre-pandemic cohorts using logistic regression results.
• Modeling the increased risk of proteinuria per unit increase in BMI based on the reported odds ratios.

Strengths

• Includes a comparative cohort of 502 pre-pandemic uninfected patients with T2DM.
• Reports specific statistical results, including a 2.682-fold higher risk (OR, 2.682; 95%CI, 1.273-5.648) for overweight/obese individuals.
• Defines a clear outcome measure: proteinuria progression as an increase in albuminuria stage assessed within three months.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is very small at 18.5 KB, indicating limited scope.

Provenance

Source

figshare, author Jiajun Wu.

Collection Method

Retrospective study.

Time Range

Data likely covers periods before and after COVID-19 infection, with assessments within three months pre- and post-infection.

Freshness

Last updated 2026-04-17 04:12:15; freshness should be verified.